| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 31.7 | 22.3 | 0.0 |
| Other income | 0.1 | 0.0 | 0.0 |
| Total income | 31.8 | 22.3 | 0.0 |
| Profit before exceptional items & tax | 4.7 | 2.5 | 0.0 |
| Profit before tax | 4.7 | 2.5 | 0.0 |
| Net profit | 3.1 | 1.9 | 0.0 |
| Operating margin | 14.8% | 11.2% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, quarter on quarter | +63.20% |
|---|
BSE results filing, BSE: 544549. Figures extracted from the filing.
Earkart Ltd: key numbers
- Share price
- ₹130.00
- Market cap
- ₹178.8 Cr
- Revenue (annual)
- ₹54.04 Cr
- Net profit (annual)
- ₹4.93 Cr
- P/E (TTM)
- 36.2×Sector 45.6×
- Promoter holding
- 57.34%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Earkart Ltd
All →Earkart Merger & Restructuring Worth ₹0.01 Cr
Earkart Limited has approved the incorporation of a wholly-owned subsidiary named SkillNest Educations Private Limited. The company will invest Rs. 0.01 Crore to explore opportunities in education services.
- Value
- ₹0.01 Cr
Earkart Annual Report
Earkart Limited has submitted its revised Annual Report for FY 2025-26. The revision rectifies a clerical omission in the Directors' Report with no financial impact.
Earkart Annual General Meeting
Earkart Limited concluded its 5th AGM on July 15, 2026. Shareholders considered resolutions for financial statement adoption, director re-appointment, and ESOP scheme amendments.
Earkart Earnings Call: Key Takeaways
Earkart Ltd reported FY26 revenue of ₹5,403.53 Lakhs and PAT of ₹493.23 Lakhs. The company is pivoting toward an integrated hearing healthcare platform using its proprietary OMNI 2.0 remote diagnostic technology.
Earkart Merger & Restructuring Worth ₹0.02 Cr
Earkart Limited approved the incorporation of two wholly-owned subsidiaries for pharmaceuticals and healthcare services. The company will invest ₹0.02 Crore across both entities to expand operations.
- Value
- ₹0.02 Cr
Earkart Other Announcement
Earkart Limited declared that its statutory auditors issued an unmodified opinion for the 2026 financial year results. This confirms the accuracy and transparency of the company's financial reporting.